Investigation into Adverum Biotechnologies, Inc. Shareholder Rights

Halper Sadeh LLC, a law firm specializing in investor rights, is investigating the sale of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) to Eli Lilly and Company. The company's shareholders may be entitled to additional consideration or disclosures due to potential fiduciary duties and securities law violations. Under the proposed transaction, shareholders will receive $3.56 per share plus a contingent value right (CVR) with a potential value of up to $8.91 per CVR. Halper Sadeh is seeking to determine whether the sale is fair to Adverum shareholders and may seek increased consideration, additional disclosures, or other relief.

Key Takeaways:

• Halper Sadeh LLC is investigating the sale of Adverum Biotechnologies, Inc. to Eli Lilly and Company on behalf of Adverum shareholders.
• The investigation concerns whether Adverum and its board of directors breached their fiduciary duties by potentially failing to obtain the best possible consideration for shareholders, determining whether Eli Lilly is underpaying, and disclosing material information.
• The proposed transaction offers $3.56 per share in cash plus a non-transferrable CVR valued at up to $8.91 per CVR upon achievement of two specific milestones.
• Halper Sadeh may seek increased consideration, additional disclosures, or other relief on behalf of Adverum shareholders, handled on a contingent fee basis.
• The firm has a history of implementing corporate reforms and recovering millions of dollars for defrauded investors.
• Attorney Advertising: Prior results do not guarantee a similar outcome.

Statistics:

• $3.56 per share: The cash amount Adverum shareholders will receive under the proposed transaction.
• $8.91 per CVR: The maximum potential value of the contingent value right (CVR) compensating Adverum shareholders upon achievement of two certain milestones.
• No specific date or time period for the proposed transaction is mentioned in the source material.

Sources:

• Halper Sadeh LLC investor alert: businesswire.com/news/home/20251025355320/en/